Novel hydroxyl dendrimer therapeutics
Location: United States, California, Redwood City
Employees: 11-50
Total raised: $69M
Investors 4
| Date | Name | Website |
| - | Deep Ventu... | deepventur... |
| - | Helios Cap... | helioscapi... |
| - | EcoR1 Capi... | ecor1cap.c... |
| 03.02.2021 | Plum Alley... | plumalley.... |
Funding Rounds 1
| Date | Series | Amount | Investors | Deal News |
| 27.04.2022 | Series B | $69M | - | globenewsw... |
Mentions in press and media 3
| Date | Title | Description | Source |
| 02.05.2022 | What to know about Elon Musk’s $12.5 billion margin loan | This is the web version of Term Sheet, a daily newsletter on the biggest deals and dealmakers. Sign ... | fortune.co... |
| 28.04.2022 | Ashvattha Therapeutics Closes $69M in Series B | REDWOOD CITY, CA, Ashvattha Therapeutics, a clinical stage company developing novel hydroxyl dendr... | vcnewsdail... |
| 27.04.2022 | Ashvattha Therapeutics Announces $69 Million in Series B Fin... | – Series B Financing led by Huadong Medicine Investment Holding Co., Ltd, with participation from Na... | globenewsw... |